Creo Medical H1 revenue rises 45% as loss narrows; expects full-year growth of 50% to 60%

Creo Medical said H1-26 revenue rose 45% year on year, operating loss narrowed by over 25% to £4.9 million, and it expects full-year revenue growth of 50% to 60%.